Canadian health care providers' and education workers' hesitance to receive original and bivalent COVID-19 vaccines
Vaccine,
Journal Year:
2024,
Volume and Issue:
42(24), P. 126271 - 126271
Published: Sept. 2, 2024
Background:
The
demand
for
COVID-19
vaccines
has
diminished
as
the
pandemic
lingers.
Understanding
vaccine
hesitancy
among
essential
workers
is
important
in
reducing
impact
of
future
pandemics
by
providing
effective
immunization
programs
delivered
expeditiously.
Method:
Two
surveys
exploring
acceptance
2021
and
2022
were
conducted
cohorts
health
care
providers
(HCP)
education
participating
prospective
studies
illnesses
uptake.
Demographic
factors
opinions
about
(monovalent
bivalent)
public
measures
collected
these
self-reported
surveys.
Modified
multivariable
Poisson
regression
was
used
to
determine
associated
with
hesitancy.
Results:
In
2021,
3
%
2061
HCP
6
3417
reported
(p
<
0.001).
December
2022,
21
868
24
1457
being
hesitant
receive
a
bivalent
=
0.09).
Hesitance
be
vaccinated
monovalent
earlier
date
survey
completion,
later
receipt
first
dose,
no
influenza
vaccination,
less
worry
becoming
ill
COVID-19.
Factors
hesitance
that
common
both
two
or
fewer
previous
doses
lower
certainty
safe
effective.
Conclusion:
Education
somewhat
more
likely
than
report
but
reasons
similar.
Hesitancy
non-receipt
(i.e.,
behaviour),
concern
infected
SARS-CoV-2,
concerns
safety
effectiveness
cohorts.
Maintaining
inter-pandemic
trust
vaccines,
ensuring
rapid
data
generation
during
regarding
effectiveness,
transparent
communication
are
all
needed
support
vaccination
programs.
Language: Английский
The Dynamics of Antibody Titres Against SARS-CoV-2 in Vaccinated Healthcare Workers: A Systemic Literature Review
Vilija Gurkšnienė,
No information about this author
Tadas Alčauskas,
No information about this author
Fausta Majauskaitė
No information about this author
et al.
Vaccines,
Journal Year:
2024,
Volume and Issue:
12(12), P. 1419 - 1419
Published: Dec. 16, 2024
Background
and
Objectives:
Given
that
COVID-19
vaccination
is
a
relatively
recent
development,
particularly
when
compared
to
immunisation
against
other
diseases,
it
crucial
assess
its
efficacy
in
vaccinated
populations.
This
literature
review
analysed
studies
monitored
antibody
titres
SARS-CoV-2
healthcare
workers
who
received
vaccines.
Methods:
Using
the
PICO
(Population,
Intervention,
Comparators,
Outcomes)
model
recommended
PRISMA
(Preferred
Reporting
Items
for
Systematic
Reviews
Meta-Analyses)
guidelines
we
included
43
publications
which
analyse
dynamics
following
primary
vaccination,
effects
of
booster
doses,
influence
factors
such
as
COVID-19C
infection,
age,
sex
on
kinetics.
Results:
All
demonstrated
strong
immunogenic
response
Re-gardless
vaccine
used,
over
95%
pre-vaccination
seronegative
population
be-came
seropositive
all
studies.
Depending
sampling
intervals
provided
by
re-searchers,
levels
were
quantitatively
highest
during
first
three
months
after
but
inevitably
declined
time.
The
monthly
decline
antibodies
observed
these
highlighted
necessity
doses.
Studies
analysing
impact
revaccination
have
confirmed
an
effective
tool
boost
humoral
immunity
SARS-CoV-2.
An-tibodies
appear
persist
longer
period
time
revaccination,
although
they
are
subject
similar
influencing
dynamics,
comorbidities,
exposure
COVID-19.
In
addition,
heterogeneous
strategies
been
shown
be
more
than
homogeneous
revaccination.
Conclusions:
Our
leaving
question
ongoing
open.
reviewed
evidence
effectiveness
despite
differences
sex,
prior
infection.
suggests
repeated
remains
highly
method
mitigating
continued
threat
posed
Language: Английский